ABCG2 has been widely reported to be a principal cause of MDR in various cancers via pumping out various antineoplastic drugs such as tyrosine kinase inhibitors (TKIs), topoisomerase inhibitors, anthracyclines etc. [21]. This evidence concerns the gene ABCG2 and cancer.